Agenus

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agenus and other ETFs, options, and stocks.

About AGEN

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777.

CEO

Garo H. Armen

CEOGaro H. Armen

Employees

316

Employees316

Headquarters

Lexington, Massachusetts

HeadquartersLexington, Massachusetts

Founded

1994

Founded1994

Employees

316

Employees316

AGEN Key Statistics

Market cap

135.17M

Market cap135.17M

Price-Earnings ratio

-0.59

Price-Earnings ratio-0.59

Dividend yield

—

Dividend yield—

Average volume

2.45M

Average volume2.45M

High today

$5.22

High today$5.22

Low today

$4.91

Low today$4.91

Open price

$5.05

Open price$5.05

Volume

426.36K

Volume426.36K

52 Week high

$18.74

52 Week high$18.74

52 Week low

$1.38

52 Week low$1.38

People also own

Based on the portfolios of people who own AGEN. This list is generated using Robinhood data, and it’s not a recommendation.

MiNK Therapeutics

Assertio

OPKO Health

Catalyst Pharmaceuticals

Unity Biotechnology

SNDL